Craig M Stolen

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications
    Craig M Stolen
    MediCity Research Laboratory, University of Turku and National Public Health Institute, Turku, Finland
    FASEB J 18:702-4. 2004
  2. ncbi Origins of serum semicarbazide-sensitive amine oxidase
    Craig M Stolen
    MediCity Research Laboratory, University of Turku and National Public Health Institute, Tykistokatu 6A, FIN 20520, Turku, Finland
    Circ Res 95:50-7. 2004
  3. ncbi Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo
    Craig M Stolen
    Department of Medical Microbiology, MediCity Research Laboratory, National Public Health Institute, Turku University, 20520 Turku, Finland
    Immunity 22:105-15. 2005
  4. ncbi Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy
    Christopher M Kirton
    Immunology Division, Department of Pathology, Cambridge University, Cambridge, UK
    Eur J Immunol 35:3119-30. 2005

Research Grants

  1. MANIPULATING VAP-1 EXPRESSION: VASCULAR PATHOLOGY MODELS
    Craig Stolen; Fiscal Year: 2003

Collaborators

Detail Information

Publications4

  1. ncbi Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications
    Craig M Stolen
    MediCity Research Laboratory, University of Turku and National Public Health Institute, Turku, Finland
    FASEB J 18:702-4. 2004
    ..These findings suggest that, although manipulation of VAP-1/SSAO has potential to serve as a therapeutic treatment in insulin-resistant conditions, care must be taken to fully understand its impact on obesity and vascular damage...
  2. ncbi Origins of serum semicarbazide-sensitive amine oxidase
    Craig M Stolen
    MediCity Research Laboratory, University of Turku and National Public Health Institute, Tykistokatu 6A, FIN 20520, Turku, Finland
    Circ Res 95:50-7. 2004
    ..An increased endothelial cell capacity for lymphocyte binding and altered expression of redox-sensitive proteins was also associated with the mTIEhVAP-1 transgene...
  3. ncbi Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo
    Craig M Stolen
    Department of Medical Microbiology, MediCity Research Laboratory, National Public Health Institute, Turku University, 20520 Turku, Finland
    Immunity 22:105-15. 2005
    ....
  4. ncbi Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy
    Christopher M Kirton
    Immunology Division, Department of Pathology, Cambridge University, Cambridge, UK
    Eur J Immunol 35:3119-30. 2005
    ..Furthermore, the chimeric antibodies prevented leukocyte adhesion and transmigration in vitro and in vivo. Hence, these chimeric antibodies have the potential to be used as a new anti-inflammatory therapy...

Research Grants1

  1. MANIPULATING VAP-1 EXPRESSION: VASCULAR PATHOLOGY MODELS
    Craig Stolen; Fiscal Year: 2003
    ..Using these mouse models, the release of soluble VAP-1 will also be investigated. Together with specific inhibitors of VAP-1, these mice will be used as models to aid in the assessment of various vascular pathology treatment modalities...